Innate immunity and genetic determinants of urinary tract infection susceptibility

Current Opinion in Infectious Diseases

Volumn 28, Issue 1, 2015, Pages 88-96

  Godaly, Gabriela ^a   Ambite, Ines ^a   Svanborg, Catharina ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

genetics; innate immunity; urinary tract infection susceptibility

Indexed keywords

TRANSCRIPTION FACTOR; TOLL LIKE RECEPTOR;

ASYMPTOMATIC BACTERIURIA; GENE DELETION; GENE EXPRESSION; GENETIC REGULATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; IMMUNOMODULATION; INFECTION RISK; INNATE IMMUNITY; MORBIDITY; NONHUMAN; PROMOTER REGION; REVIEW; URINARY TRACT INFECTION; ANIMAL; BACTERIURIA; ESCHERICHIA COLI INFECTION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; KNOCKOUT MOUSE; MICROBIOLOGY; MOUSE; PATHOLOGY; PROGNOSIS; PYELONEPHRITIS; RISK FACTOR; SIGNAL TRANSDUCTION;

ANIMALS; BACTERIURIA; ESCHERICHIA COLI INFECTIONS; GENETIC PREDISPOSITION TO DISEASE; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; MICE; MICE, KNOCKOUT; POLYMORPHISM, GENETIC; PROGNOSIS; PYELONEPHRITIS; RISK FACTORS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; URINARY TRACT INFECTIONS;

EID: 84920829514     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0000000000000127     Document Type: Review

References (68)

1. Ragnarsdottir B, Lutay N, Gronberg-Hernandez J, et al. Genetics of innate immunity and UTI susceptibility. Nat Rev Urol 2011; 8:449-468.
2. Zivkovic M, Stojkovic L, Spasojevic-Dimitrijeva B, et al. Genetic factors underlying susceptibility to acute pyelonephritis and postinfectiious damage. In: Recent advances in the field of urinary tract infections. Nelius T; chapter 7,2013.
3. Lundstedt AC, Leijonhufvud I, Ragnarsdottir B, et al. Inherited susceptibility to acute pyelonephritis: a family study of urinary tract infection. J Infect Dis 2007; 195:1227-1234.
4. Scholes D, Hawn TR, Roberts PL, et al. Family history and risk of recurrent cystitis and pyelonephritis in women. J Urol 2010; 184:564-569.
5. Scholes D, Hooton TM, Roberts PL, et al. Risk factors for recurrent urinary tract infection in young women. J Infect Dis 2000; 182:1177-1182.
6. Svanborg C. Urinary tract infections in children: microbial virulence versus host susceptibility. Adv Exp Med Biol 2013; 764:205-210.
7. Ragnarsdottir B, Svanborg C. Susceptibility to acute pyelonephritis or asymptomatic bacteriuria: host-pathogen interaction in urinary tract infections. Pediatr Nephrol 2012; 27:2017-2029.
8. Nielubowicz GR, Mobley HL. Host-pathogen interactions in urinary tract infection. Nat Rev Urol 2010; 7:430-441.
9. Leffler H, Svanborg-Edén C. Chemical identification of a glycosphingolipid receptor for escherichia coli attaching to human urinary tract epithelial cells and agglutinating human erythrocytes. FEMS Microbiol Lett 1980; 8:127-134.
10. Hedlund M, Svensson M, Nilsson A°, et al. Role of the ceramide signalling pathway in cytokine responses to p fimbriated escherichia coli. J Exp Med 1996; 183:1-8.
11. Fischer H, Lutay N, Ragnarsdottir B, et al. Pathogen specific, irf3-dependent signaling and innate resistance to human kidney infection. PLoS Path 2010; 6:e1001109.
12. Yamamoto M, Sato S, Hemmi H, et al. Essential role for tirap in activation of the signalling cascade shared by tlr2 and tlr4. Nature 2002; 420:324-329.
13. Schwartz DJ, Kalas V, Pinkner JS, et al. Positively selected fimh residues enhance virulence during urinary tract infection by altering fimh conformation. Proc Natl Acad Sci U S A 2013; 110:15530-15537.
14. Lane MC, Alteri CJ, Smith SN, Mobley HL. Expression of flagella is coincident with uropathogenic escherichia coli ascension to the upper urinary tract. Proc Natl Acad Sci U S A 2007; 104:16669-16674.
15. Miao Y, Abraham SN. Kidney alpha-intercalated cells and lipocalin 2: defending the urinary tract. J Clin Invest 2014; 124:2844-2846.
16. Ingersoll MA, Albert ML. From infection to immunotherapy: host immune responses to bacteria at the bladder mucosa. Mucosal Immunol 2013; 6:1041-1053.
17. Lutay N, Ambite I, Hernandez JG, et al. Bacterial control of host gene expression through RNA polymerase ii. J Clin Invest 2013; 123:2366-2379.
18. Godaly G, Bergsten G, Hang L, et al. Neutrophil recruitment, chemokine receptors, and resistance to mucosal infection. J Leuk Biol 2001; 69:899-906.
19. Ambite I, Lutay N, Godaly G, Svanborg C. Urinary tract infections and the mucosal immune system. In: Mucosal Immunology, 4th edition. Mestecky J, Strober W, Russell MW, Cheroutre H, Lambrecht BN, Kelsall B, editors, chapter 105, 2015.
20. Nielsen KL, Dynesen P, Larsen P, Frimodt-Moller N. Role of urinary cathelicidin ll-37 and human beta-defensin 1 in uncomplicated Escherichia coli urinary tract infections. Infect Immun 2014; 82:1572-1578.
21. Morrison G, Kilanowski F, Davidson D, Dorin J. Characterization of the mouse beta defensin 1, defb1, mutant mouse model. Infect Immun 2002; 70:3053-3060.
22. Shahin R, Engberg I, Hagberg L, Svanborg-Edén C. Neutrophil recruitment and bacterial clearance correlated with lps responsiveness in local gramnegative infection. J Immunol 1987; 138:3475-3480.
23. Hopkins W, Gendron-Fitzpatrick A, McCarthy DO, et al. Lipopolysaccharide responder and nonresponder c3 h mouse strains are equally susceptible to an induced escherichia coli urinary tract infection. Infect Immun 1996; 64:1369-1372.
24. Poltorak A, He X, Smirnova I, et al. Defective lps signaling in c3 h/hej and c57bl/10sccr mice: mutations in tlr4 gene. Science 1998; 282:2085-2088.
25. Beutler B. Tlr4: central component of the sole mammalian lps sensor. Curr Opin Immunol 2000; 12:20-26.
26. Hagberg L, Briles D, Svanborg-Edén C. Evidence for separate genetic defects in c3 h/hej and c3heb/fej mice that affect the susceptibility to gram-negative infections. J Immunol 1985; 134:4118-4122.
27. Samuelsson P, Hang L, Wullt B, et al. Toll-like receptor 4 expression and cytokine responses in the human urinary tract mucosa. Infect Immun 2004; 72:3179-3186.
28. Hagberg L, Hull R, Hull S, et al. Difference in susceptibility to gram-negative urinary tract infection between c3 h/hej and c3 h/hen mice. Infect Immun 1984; 46:839-844.
29. Yadav M, Zhang J, Fischer H, et al. Inhibition of tir domain signaling by tcpc: Myd88-dependent and independent effects on escherichia coli virulence. PLoS Path 2010; 6:e1001120.
30. Fischer H, Yamamoto M, Akira S, et al. Mechanism of pathogen-specific tlr4 activation in the mucosa: fimbriae, recognition receptors and adaptor protein selection. Eur J Immunol 2006; 36:267-277.
31. Svanborg C. Innate immunity and genetics of UTI susceptibility urinary tract infection; molecular advances and novel therapies. In: Molecular UTI Conference: Urinary Tract Infection: Molecular Advances and Novel Therapies, 25-27 August 2014, Malmö, Sweden; 2014.
32. Godaly G, Hang L, Frendeus B, Svanborg C. Transepithelial neutrophil migration is cxcr1 dependent in vitro and is defective in il-8 receptor knockout mice. J Immunol 2000; 165:5287-5294.
33. Frendeus B, Godaly G, Hang L, et al. Interleukin 8 receptor deficiency confers susceptibility to acute experimental pyelonephritis and may have a human counterpart. J Exp Med 2000; 192:881-890.
34. Hang L, Frendeus B, Godaly G, Svanborg C. Interleukin-8 receptor knockout mice have subepithelial neutrophil entrapment and renal scarring following acute pyelonephritis. J Infect Dis 2000; 182:1738-1748.
35. Svensson M, Irjala H, Alm P, et al. Natural history of renal scarring in susceptible mil-8rh-/- mice. Kidney Int 2005; 67:103-110.
36. Svensson M, Irjala H, Svanborg C, Godaly G. Effects of epithelial and neutrophil cxcr2 on innate immunity and resistance to kidney infection. Kidney Int 2008; 74:81-90.
37. Boman H. Antibacterial peptides: key components needed in immunity. Cell 1991; 65:205-207.
38. Chromek M, Slamova Z, Bergman P, et al. The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacteria. Nat Med 2006; 12:636-641.
39. Zasloff M. The antibacterial shield of the human urinary tract. Kidney Int 2013; 83:548-550.
40. Zhang D, Zhang G, Hayden MS, et al. A toll-like receptor that prevents infection by uropathogenic bacteria. Science 2004; 303:1522-1526.
41. Hains DS, Chen X, Saxena V, et al. Carbonic anhydrase 2 deficiency leads to increased pyelonephritis susceptibility. Am J Physiol Renal Physiol 2014; 307:F869-F880.
42. Pak J, Pu Y, Zhang ZT, et al. Tamm-Horsfall protein binds to type 1 fimbriated Escherichia coli and prevents E. coli from binding to uroplakin ia and ib receptors. J Biol Chem 2001; 276:9924-9930.
43. Schmid M, Prajczer S, Gruber LN, et al. Uromodulin facilitates neutrophil migration across renal epithelial monolayers. Cell Physiol Biochem 2010; 26:311-318.
44. Bates JM, Raffi HM, Prasadan K, et al. Tamm-Horsfall protein knockout mice are more prone to urinary tract infection: rapid communication. Kidney Int 2004; 65:791-797.
45. Dou W, Thompson-Jaeger S, Laulederkind SJ, et al. Defective expression of Tamm-Horsfall protein/uromodulin in cox-2-deficient mice increases their susceptibility to urinary tract infections. Am J Physiol Renal Physiol 2005; 289:F49-F60.
46. Andersen-Nissen E, Hawn TR, Smith KD, et al. Cutting edge: Tlr5-/- mice are more susceptible to Escherichia coli urinary tract infection. J Immunol 2007; 178:4717-4720.
47. Svanborg C, Ambite I, Godaly G. Genetic control of acute cystitis: IL-1β and inflammasome dysregulation. In: Molecular UTI Conference: Urinary Tract Infection: Molecular Advances and Novel Therapies, 25-27 August 2014; Malmö, Sweden.
48. Ragnarsdottir B, Samuelsson M, Gustafsson MC, et al. Reduced toll-like receptor 4 expression in children with asymptomatic bacteriuria. J Infect Dis 2007; 196:475-484.
49. Ragnarsdottir B, Jonsson K, Urbano A, et al. Toll-like receptor 4 promoter polymorphisms: common tlr4 variants may protect against severe urinary tract infection. PLoS One 2010; 5:e10734.
50. Hawn TR, Scholes D, Li SS, et al. Toll-like receptor polymorphisms and susceptibility to urinary tract infections in adult women. PLoS One 2009; 4:e5990.
51. Tabel Y, Berdeli A, Mir S. Association of tlr2 gene arg753gln polymorphism with urinary tract infection in children. Int J Immunogenet 2007; 34:399-405.
52. Lundstedt AC, McCarthy S, Gustafsson MC, et al. A genetic basis of susceptibility to acute pyelonephritis. PLoS One 2007; 2:e825.
53. Artifoni L, Negrisolo S, Montini G, et al. Murer L: interleukin-8 and cxcr1 receptor functional polymorphisms and susceptibility to acute pyelonephritis. J Urol 2007; 177:1102-1106.
54. Centi S, Negrisolo S, Stefanic A, et al. Upper urinary tract infections are associated with rantes promoter polymorphism. J Pediatr 2010; 157:1038-1040.
55. Hussein A, Askar E, Elsaeid M, Schaefer F. Functional polymorphisms in transforming growth factor-beta-1 (tgfbeta-1) and vascular endothelial growth factor (vegf) genes modify risk of renal parenchymal scarring following childhood urinary tract infection. Nephrol Dial Transplant 2010; 25:779-785.
56. Smirnova I, Hamblin MT, McBride C, et al. Excess of rare amino acid polymorphisms in the toll-like receptor 4 in humans. Genetics 2001; 158:1657-1664.
57. Gbadegesin RA, Cotton SA, Watson CJ, et al. Association between icam-1 gly-arg polymorphism and renal parenchymal scarring following childhood urinary tract infection. Int J Immunogenet 2006; 33:49-53.
58. Watson CJ, Webb NJ, Bottomley MJ, Brenchley PE. Identification of polymorphisms within the vascular endothelial growth factor (vegf) gene: correlation with variation in vegf protein production. Cytokine 2000; 12:1232-1235.
59. Cotton SA, Gbadegesin RA, Williams S, et al. Role of tgf-beta1 in renal parenchymal scarring following childhood urinary tract infection. Kidney Int 2002; 61:61-67.
60. Stevens A, Soden J, Brenchley PE, et al. Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. Cancer Res 2003; 63:812-816.
61. Yim HE, Bae IS, Yoo KH, et al. Genetic control of vegf and tgf-beta1 gene polymorphisms in childhood urinary tract infection and vesicoureteral reflux. Pediatr Res 2007; 62:183-187.
62. Zaffanello M, Tardivo S, Cataldi L, et al. Genetic susceptibility to renal scar formation after urinary tract infection: a systematic review and metaanalysis of candidate gene polymorphisms. Pediatr Nephrol 2011; 26:1017-1029.
63. Lomberg H, Hanson L, Jacobsson B, et al. Correlation of P blood group phenotype, vesicoureteral reflux and bacterial attachment in patients with recurrent pyelonephritis. N Engl J Med 1983; 308:1189-1192.
64. Lomberg H, Jodal U, Svanborg-EdénC, et al. P1 blood group and urinary tract infection. Lancet 1981; i:551-552.
65. Stapleton A, Nudelman E, Clausen H, et al. Binding of uropathogenic Escherichia coli r45 to glycolipids extracted from vaginal epithelial cells is dependent on histo-blood group secretor status. J Clin Invest 1992; 90:965-972.
66. Lindstedt R, Larson G, Falk P, et al. The receptor repertoire defines the host range for attaching escherichia coli strains that recognize globo-a. Infect Immun 1991; 59:1086-1092.
67. Cirl C, Wieser A, Yadav M, et al. Subversion of toll-like receptor signaling by a unique family of bacterial toll/interleukin-1 receptor domain-containing proteins. Nat Med 2008; 14:399-406.
68. Zdziarski J, Brzuszkiewicz E, Wullt B, et al. Host imprints on bacterial genomes - rapid, divergent evolution in individual patients. PLoS Path 2010; 6:e1001078.